Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh, Tien-Phat V., Davis, Albert A., Ulrich, Jason D., Holtzman, David M.·2017·Journal of Lipid Research

DOI 10.1194/jlr.r075481

Cited by (210)

Items 101–200 of 210

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
Farida Dakterzada, Mariona Jové, Raquel P Huerto, Anna Carnes, Joaquím Sol, Reinald Pamplona, Gerard Piñol‐Ripoll · 2023 · Aging and Disease
Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer’s Disease
Patra, Kalicharan, Giannisis, Andreas, Edlund, Anna K., Sando, Sigrid Botne, Lauridsen, Camilla, Berge, Guro, Grøntvedt, Gøril Rolfseng, Bråthen, Geir, White, Linda R., Nielsen, Henrietta M. · 2019 · Journal of Alzheimer's Disease
The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction
Keith W. VanDusen, Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, Kenneth Roberts, John Whittle, Jeffrey N. Browndyke et al. · 2020 · Journal of Alzheimer s Disease
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
Valencia-Olvera, Ana C., Balu, Deebika, Faulk, Naomi, Amiridis, Aspasia, Wang, Yueting, Pham, Christine, Avila-Munoz, Eva, York, Jason M., Thatcher, Gregory R.J., LaDu, Mary Jo · 2023 · Neurotherapeutics
Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
Yasuteru Inoue, Yukio Ando, Yohei Misumi, Mitsuharu Ueda · 2021 · International Journal of Molecular Sciences
Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
Weimin Qiu, Hui Liu, Yijun Liu, Xin Lü, Lei Wang, Yanyu Hu, Feng Feng, Qi Li, Haopeng Sun · 2023 · Medicinal Research Reviews
Molecular modeling of apoE in complexes with Alzheimer’s amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids
Emily Lewkowicz, Mari N. Nakamura, Michael J. Rynkiewicz, Olga Gursky · 2023 · Cellular and Molecular Life Sciences
Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease
Parisa Faraji, Hartmut Kühn, Shahin Ahmadian · 2024 · Journal of Molecular Neuroscience
Elevated lipopolysaccharide binding protein in Alzheimer’s disease patients with APOE3/E3 but not APOE3/E4 genotype
Eduardo Z. Romo, Brian V. Hong, Rishi Y. Patel, Joanne Agus, Danielle Jenine Harvey, Izumi Maezawa, Lee‐Way Jin, Carlito B. Lebrilla, Angela M. Zivkovic · 2024 · Frontiers in Neurology
Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease
Jennifer Hua, Elvira Garcia De Paco, Nathalie Linck, Tangui Maurice, Catherine M. Desrumaux, Bénédicte Manoury, François Rassendren, Lauriane Ulmann · 2023 · Cellular and Molecular Life Sciences
Future horizons in Alzheimer's disease research
Thomas Wısnıewskı, Eleanor Drummond · 2019 · Progress in molecular biology and translational science
Analyzing alternative splicing in Alzheimer’s disease postmortem brain: a cell-level perspective
Mohammad‐Erfan Farhadieh, Kamran Ghaedi · 2023 · Frontiers in Molecular Neuroscience
Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Anna Bonaterra‐Pastra, Sofía Fernández de Retana, Andrea Rivas-Urbina, Núria Puig, Sònia Benı́tez, Olalla Pancorbo, David Rodríguez‐Luna, Francesc Pujadas, María del Mar Freijo, Sílvia Tur et al. · 2021 · Biomedicines
A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease
Jana Harenbrock, Heinz Holling, Graham Reid, Ivan G. Koychev · 2023 · Biomarkers in Neuropsychiatry
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yifan Yu, Shilong Yu, Giuseppe Battaglia, Xiaohe Tian · 2024 · Ibrain
Genome-wide identification of novel long non-coding RNAs and their possible roles in hypoxic zebrafish brain
Bodhisattwa Banerjee, Debaprasad Koner, David Karasik, Nirmalendu Saha · 2020 · Genomics
Trends in glycolipid biomarker discovery in neurodegenerative disorders by mass spectrometry
Dehelean, Liana, Sarbu, Mirela, Petrut, Alina, Zamfir, Alina D. · 2019 · Advances in experimental medicine and biology
Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review
Tian-Wen Lou, Borui Tao, Ming Chen · 2023 · Neuroscience
Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s disease
Xiaoling Wang, Xiaomin Zhang, Jing Liu, Jingjing Zhang, Congcong Liu, Yuting Cui, Qiao Song, Yuli Hou, Yaqi Wang, Qian Zhang et al. · 2024 · Alzheimer s Research & Therapy
Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
Morteza Abyadeh, Vivek Gupta, João A. Paulo, Samran Sheriff, Sina Shadfar, Matthew J. Fitzhenry, Ardeshir Amirkhani, Veer Bala Gupta, Ghasem Hosseini Salekdeh, Paul A. Haynes et al. · 2023 · Aging and Disease
Real-Time Analysis of Specific Binding between Apolipoprotein E Isoforms and Amyloid β-Peptide by Dual Polarization Interferometry
Yu Wang, Yu Xue, Shuang Wang, Jianshe Huang, Xiurong Yang · 2020 · Analytical Chemistry
Mitochondria-Microbiota Interaction in Neurodegeneration
Peter Krämer · 2021 · Frontiers in Aging Neuroscience
ApoE Mimic Peptide COG1410 Reduces Aβ Deposition and Improves Cognitive Function by Inducing the Transformation of A1/A2 Reactive Astrocytes and Increasing the BDNF Concentration in Brain of APP/PS1 Double Transgenic Mice
Yue Qiao, Hang Liu, Chaoying He, Ying Ma · 2023 · Neuroscience
Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype
Lawler, Paige E., Bollinger, James G., Schindler, Suzanne E., Hodge, Cynthia R., Iglesias, Nicolas J., Krishnan, Vishal, Coulton, John B., Li, Yan, Holtzman, David M., Bateman, Randall J. · 2023 · Analytical Biochemistry
An aptamer‐based magnetic resonance imaging contrast agent for detecting oligomeric amyloid‐β in the brain of an Alzheimer's disease mouse model
Sang‐Tae Kim, Hyug‐Gi Kim, Yu Mi Kim, Ho‐Seong Han, Jee‐Hyun Cho, Sung‐Chul Lim, Taekwan Lee, Geon‐Ho Jahng · 2022 · NMR in Biomedicine
Amyloid-peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4
Ioannis Dafnis, Letta Argyri, Angeliki Chroni · 2018 · Neuroscience
Knockout of apolipoprotein A‐I decreases parenchymal and vascular β‐amyloid pathology in the Tg2576 mouse model of Alzheimer's disease
Laura Contu, Roxana Octavia Carare, Cheryl A. Hawkes · 2019 · Neuropathology and Applied Neurobiology
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, Keith A. Webster, Lina A. Shehadeh · 2023 · Biomedicines
Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
Anna Bonaterra‐Pastra, Sònia Benítez, Olalla Pancorbo, David Rodríguez‐Luna, Carla Vert, Àlex Rovira, María del Mar Freijo, Sílvia Tur, Maite Martínez-Zabaleta, Pere Cardona Portela et al. · 2023 · Frontiers in Aging Neuroscience
Evaluation of Associations of Alzheimer’s Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures
Nobutaka Sakae, Michael G. Heckman, Emily R Vargas, Minerva M. Carrasquillo, Melissa Erin Murray, Koji Kasanuki, Nilüfer Ertekin‐Taner, Steven G. Younkin, Dennis W. Dickson · 2019 · Journal of Alzheimer s Disease
Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement
Gangfuß, Andrea, Czech, Artur, Hentschel, Andreas, Münchberg, Ute, Horvath, Rita, Töpf, Ana, O'Heir, Emily, Lochmüller, Hanns, Stehling, Florian, Kiewert, Cordula et al. · 2022 · The Journal of Pathology
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
Amandeep Thakur, Mandeep Rana, Sakshi Vanjani, Ke-Chi Liou, Rajeev Taliyan, Kunal Nepali, Chih‐Hao Yang · 2026 · Medicinal Research Reviews
Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction
Shane Gordon, Leane Hoey, Helene McNulty, Jordan Keenan, Faith Pangilinan, Lawrence C. Brody, Mary H. Ward, James J. Strain, Liadhan B. McAnena, Adrian McCann et al. · 2025 · BMC Medicine
Neuropsychiatric Inventory–Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer’s Disease Predict More Rapid Cognitive Deterioration
Adrienne Lloyd Atayde, Corinne Eleanor Fischer, Tom A. Schweizer, David G. Muñoz · 2022 · Journal of Alzheimer s Disease
Protein Interactome of Amyloid-β as a Therapeutic Target
Lazarev, Vladimir F., Dutysheva, Elizaveta A., Kanunikov, Igor E., Guzhova, Irina V., Margulis, Boris A. · 2023 · Pharmaceuticals
The vascular risk factors and vascular neuropathology in subjects with autopsy‐confirmed dementia with Lewy bodies
Zhi‐Chao Chen, Jinghuan Gan, Yaqi Yang, Qingbo Meng, Jiuyan Han, Yong Ji · 2022 · International Journal of Geriatric Psychiatry
Modeling sporadic Alzheimer’s disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors
Kiruthika Ganesan, Peggy Rentsch, Alexander Langdon, Luke T. Milham, Bryce Vissel · 2024 · Frontiers in Aging Neuroscience
Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
Gunnar K. Gouras · 2019 · Frontiers in Aging Neuroscience
Effect of ginkgolide K on calcium channel activity in Alzheimer's disease
Hongbin Liu, Qinyun Li, Xiaodan Zhang, Yun Shi, Jinyi Li · 2022 · Experimental and Therapeutic Medicine
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
Ladan Gol Mohammad Pour Afrakoti, Sanam Daneshpour Moghadam, Pezhman Hadinezhad · 2025 · Journal of Alzheimer s Disease Reports
Multiple ischemic strokes in a patient treated with Lecanemab: a case report
Hajar Alammar, Mamadou Diallo, Daniel A. Llano · 2025 · Neurocase
Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
Virendra Tiwari, Shubha Shukla · 2023 · Frontiers in Genetics
New APOE-related therapeutic options for Alzheimer’s disease
Ziying Li · 2019 · AIP conference proceedings
N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21
Hiromitsu Toshikawa, Akihiro Ikenaka, Li Li, Yoko Nishinaka‐Arai, Akira Niwa, Akira Ashida, Yasuhiro Kazuki, Tatsutoshi Nakahata, Hiroshi Tamai, David W. Russell et al. · 2021 · Scientific Reports
ApoE4 Upregulates GSK ‐3β to Aggravate Alzheimer‐Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice
Yuying Wang, Yang Gao, Yarong Wang, Fuqiang Zhang, Fei Sun, Xin Wang, Jiazhao Xie, Zhipeng Xu, Junjian Zhang, Haibo Xu et al. · 2025 · CNS Neuroscience & Therapeutics
Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology
Printha Wijesinghe, Hao Ran Li, Zhengdong Ai, Matthew Campbell, Si Xuan Chen, Jeanne Xi, Wellington N. Pham, Joanne Aiko Matsubara · 2024 · Frontiers in Aging Neuroscience
Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease
Ernest Amponsah Asiamah, Baofeng Feng, Ruiyun Guo, Wei Zhang, Jingjing He, Desheng Kong, Tianyu Dong, Jun Ma, Huixian Cui · 2020 · Reviews in the Neurosciences
Correlation of peripheral olfactomedin 1 with Alzheimer’s disease and cognitive functions
Chunxiao Wei, Guimei Zhang, Xiaoshu Fu, Meng Liang Zhao, Weijie Zhai, Yanxin Shen, Li Sun · 2025 · Translational Psychiatry
Serum noncholesterol sterols in Alzheimer's disease: the Helsinki Businessmen Study
Chaiyasit Sittiwet, Piia P. Simonen, Markku J. Nissinen, Helena Gylling, Timo E. Strandberg · 2018 · Translational research
Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer’s Disease
Guilian M. Xu, Susan Fromholt, David Borchelt · 2022 · Biomolecules
Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk
Jin Ma, Shizheng Qiu · 2022 · Frontiers in Neuroscience
Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer’s Disease
Oldham CE, Dayami Lopez · 2018 · International Journal of Biomedical Investigation
Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer’s Disease
Erica Staurenghi, Gabriella Testa, Valerio Leoni, Rebecca Cecci, Lucrezia Floro, Serena Giannelli, Eugenio Barone, Marzia Perluigi A, Gabriella Leonarduzzi, Barbara Sottero et al. · 2024 · Antioxidants
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Matheus V. Coste Grahl, Kelvin Siqueira Hohl, Thiago Ângelo Smaniotto, Célia R. Carlini · 2025 · Molecules
The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
NHE6-Depletion Corrects ApoE4-Mediated Synaptic Impairments and Reduces Amyloid Plaque Load
Theresa Pohlkamp, Xunde Xian, Connie Hau Yan Wong, Murat S. Durakoglugil, Gordon C Werthmann, Takaomi Saido, Bret M. Evers, Charles L. White, Jade Connor, Robert E. Hammer et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid deposition
David Borchelt · 2018 · Journal of Clinical Investigation
Sex significantly predicts medial temporal volume when controlling for the influence of ApoE4 biomarker and demographic variables: A cross-ethnic comparison
Patricia Garcia, Lisandra Mendoza, Dilianna Padrón, Andres Duarte, Ranjan Duara, David Loewenstein, Maria T. Greig‐Custo, Warren Barker, Rosie E. Curiel, Mónica Rosselli et al. · 2023 · Journal of the International Neuropsychological Society
Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer’s Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee Diets
Ashok Kumar, Amit Pal, Parminder Singh, Isha Rani, Vincenzo Tondolo, Mauro Ciro Antonio Rongioletti, Rosanna Squitti · 2023 · Biological Trace Element Research
Apolipoprotein E interacts with amyloid-β oligomers via positively cooperative multivalent binding
Swagatha Ghosh, Timir Baran Sil, Sukanta Dolai, Kanchan Garai · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Increased tau expression in the APOE4 blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery in vitro
Joanna Marta Wasielewska, Rinie Bajracharya, Rebecca L. Johnston, Juliana C.S. Chaves, Alice Pébay, Lotta E. Oikari, Jürgen Götz, Rebecca M. Nisbet, Anthony Robert White · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Suboptimal self‐reported sleep efficiency and duration are associated with faster accumulation of brain amyloid beta in cognitively unimpaired older adults
Louise N Pivac, Belinda M. Brown, Kelsey R. Sewell, James D. Doecke, Victor L. Villemagne, Vincent Doré, Michael Weinborn, Hamid Reza Sohrabi, Samantha L. Gardener, Romola Starr Bucks et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
The Differential Effects of APOE ɛ4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations
Mingyu Tang, Ning Su, Dingding Zhang, Yi Dai, Ming Yao, Lixin Zhou, Liying Cui, Shuyang Zhang, Yi‐Cheng Zhu, Jun Ni · 2023 · Journal of Alzheimer s Disease
Research progress and future development direction of Alzheimer's therapy
Dingjiayi Zhai · 2024 · Theoretical and Natural Science
Trajectories of amyloid beta accumulation – Unveiling the relationship with APOE genotype and cognitive decline
Maha Wybitul, Andreas Buchmann, Nicolas Langer, Christoph Höck, Valérie Treyer, Anton Franz Gietl · 2024 · Neurobiology of Aging
Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models
Jang Woo Park, Yunan Tian, Sang‐Tae Kim, Chan-Woo Park, Yu Mi Kim, Hye Kyung Chung, Kyeong Min Kim, Geon‐Ho Jahng · 2024 · Frontiers in Pharmacology
Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
Anita Mollica, Giuseppe Berardino, Antonello Bellomo, Mario Altamura, Francesco Panza, Madia Lozupone · 2024 · Springer eBooks
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
Tapas Kumar Sur, Tanmoy Mondal, Zarish Noreen, Jheannelle Johnson, Gail Nunlee‐Bland, Christopher A. Loffredo, Brent E. Korba, Vijay Chandra, Siddhartha S. Jana, Bernard Kwabi‐Addo et al. · 2025 · Biomarkers in Neuropsychiatry
Clinical response to cholinesterase inhibitors in dementia
Luís Felipe José Ravic de Miranda, Karina Braga Gomes, Paulo Caramelli · 2020 · Elsevier eBooks
Gene–Diet Interaction Analysis in UK Biobank Identified Genetic Loci That Modify the Association Between Fish Oil Supplementation and the Incidence of Dementia
Yueqi Lu, Huifang Xu, Yitang Sun, Susan Adanna Ihejirika, Charleston W. K. Chiang, Burcu F. Darst, Suhang Song, Ye Shen, Kaixiong Ye · 2025 · Current Developments in Nutrition
Cognitive Decline and Neurodegenerative Markers in Psoriasis: The Role of APOE4 and Beta-Amyloid
Hanan Hassan Sabry, Bassma Qassim Kadhum, Ghid Nahd Abdulmohsin, Amira Osama Abd El-Ghaffar, Marwa Mohamed Mahmoud, Ghada M. Shams · 2026 · Dermatology Practical & Conceptual
Genetic Architecture of Cognitive Resilience in Alzheimer’s Disease: Mechanisms, Pathways, and Therapeutic Implications
Gabriel Burdman, Juliet Akkaoui, Natalia Colon, A. Garcia Perez, Madepalli Krishnappa Lakshmana · 2026 · Neurology International
Meta-analysis reveals apolipoprotein ε4 confers higher susceptibility to Parkinson’s disease dementia in Asian populations
Naseem Akhter, Ngoc Anh Ho, Ryan C. Nangreave, Saif Ahmad, Andrew F. Ducruet, Kanchan Bhatia · 2026 · Frontiers in Aging Neuroscience
Impact of previous statin use on first intracerebral hemorrhage in cerebral amyloid angiopathy
C. Helven, Julien Burel, Margot Vannier, David Maltête, Ozlem Ozkul-Wermester, Capucine Hermary, David Wallon, Lou Grangeon · 2023 · Revue Neurologique
Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
Carlos Gutiérrez‐Merino · 2025 · Exploration of neuroscience
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Cody Allen, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's Disease Investigated via Gene-Environment Interactions, Biochemical Pathways, Cellular Processes, and Disease Phenotype Variability
Viqas Shafi, Ifrah Siddiqui · 2024 · Research Square
Studying Vascular Morphologies in the Aged Human Brain Using Large Autopsy Datasets
Eseosa T. Ighodaro · 2018 · UKnowledge (University of Kentucky)
Clinical Validation of Neuronal Pentraxin Receptor as a Candidate Biomarker for Alzheimer’s Disease
Bryant Lim · 2020 · TSpace (University of Toronto)
Microglial P2X4 receptors promote ApoE degradation and cognitive deficits in Alzheimer disease
Jennifer Hua, Elvira Garcia De Paco, Nathalie Linck, Tangui Maurice, Catherine M. Desrumaux, Bénédicte Manoury, François Rassendren, Lauriane Ulmann · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype
Paige E. Lawler, James G. Bollinger, Suzanne E. Schindler, Cynthia R. Hodge, Nicolas J. Iglesias, Vishal Krishnan, John B. Coulton, Yan Li, David M. Holtzman, Randall John Bateman · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Cerebrospinal fluid neutral lipids are associated with Alzheimer’s disease progression
Farida Dakterzada, Mariona Jové, Raquel P Huerto, Anna Carnes, Joaquím Sol, Reinald Pamplona, Gerard Piñol‐Ripoll · 2023 · Research Square
Human APOE allelic variants suppress the formation of diffuse and fibrillar Aβ deposits relative to mouse Apoe in transgenic mouse models of Alzheimer amyloidosis
Guilian M. Xu, Patricia Sacilotto, Carmelina Gorski, Parul Bali, Susan Fromholt, Quan Vo, Karen N. McFarland, Qing Lu, David Borchelt, Paramita Chakrabarty · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Relationship Between Dyslipidemia and Alzheimer’s Disease
Murat Bolayırlı, Mine Kücür · 2024
Prevention and Reduction of Risk of AD: Lifestyle Changes, Dietary Changes, Supplements, and More
Ashish Sriram Mishra, Manimaran Vasanthan, Swati Swagatika Swain, Veera Venkata Satyanarayana Reddy Karri · 2024 · Springer eBooks
Differential Effects of Aβ Peptides on the Plasmin-Dependent Degradation of ApoE3 and ApoE4
Merc M. Kemeh, Anthony J. Furnelli, Noel D. Lazo · 2025 · ACS Chemical Neuroscience
EnSCAN: ENsemble Scoring for prioritizing CAusative variaNts across multiplatform GWASs for late-onset alzheimer’s disease
Onur Erdogan, Cem İyigün, Yeşim Aydın Son · 2025 · BioData Mining
Synergistic effects of APOE ε4 and Alzheimer’s pathology on the neural correlates of episodic remembering in cognitively unimpaired older adults
Alexandra N. Trelle, Jintao Sheng, Edward N. Wilson, America Romero, Jennifer Park, Gayle Karen Deutsch, Sharon J. Sha, Michael D. Greicius, Katrin I. Andreasson, Geoffrey A. Kerchner et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Protein biomarker discovery for canine cognitive dysfunction syndrome based on molecular alterations observed in nasal fluids
Jiwon Chae, Mina Choi, Juyoung Choi, Seung‐Jun Yoo · 2025 · Research Square
Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
Anita Mollica, Giuseppe Berardino, Antonello Bellomo, Mario Altamura, Francesco Panza, Madia Lozupone · 2025 · Springer eBooks
Anti-amyloid antibodies for the treatment of early-stage Alzheimer’s disease
Kristian Steen Frederiksen, Mathias Holsey Gramkow, Steen Gregers Hasselbalch, Ian G. Law, Gunhild Waldemar · 2025 · Ugeskrift for Læger
The Cognitive Changes Among Patients over 65 Years of Age in a Rural Area—The Preliminary Report of Protective and Predisposing Factors
Radosław Zachara, Daria Gendosz de Carrillo, Adam Właszczuk, Agnieszka Gorzkowska, Wiktoria Mazur, Halina Jędrzejowska–Szypułka · 2025 · Neurology International
Additional file 13 of Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Allen, Cody, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2022 · Figshare
Additional file 1 of Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis
Guilian M. Xu, Susan Fromholt, Paramita Chakrabarty, Fanchao Zhu, Liu, Xuefei, Michael C. Pace, Jin Koh, TODD E GOLDE, Yona Levites, Jada M. Lewis et al. · 2020 · Figshare
Additional file 12 of Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Allen, Cody, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2022 · Figshare
Additional file 6 of Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis
Guilian M. Xu, Susan Fromholt, Paramita Chakrabarty, Fanchao Zhu, Liu, Xuefei, Michael C. Pace, Jin Koh, Golde, Todd E., Yona Levites, Jada M. Lewis et al. · 2020 · Figshare
Additional file 1 of Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s disease
Wang, Xiaoling, Xiaomin Zhang, Jing Liu, Jingjing Zhang, Congcong Liu, Yuting Cui, Song, Qiao, Yuli Hou, Wang, Yaqi, Zhang, Qian et al. · 2024 · Figshare
Additional file 11 of Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Allen, Cody, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2022 · Figshare
A Review of Interaction Between Sleep Apnea and APOE e4 on the Risk of Dementia
Xiuhua Ding, Carol Watwood, Amit Patel, Krupa Hegde, Brooke Mahanna, Lindsey Escudero, jean Neils-Strunjas · 2026 · Journal of Gerontology and Geriatrics
Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment
Xitian Wang, Chunhua Zhang, Xiaocong Liu, Yaojun Tai, Guozhao Ma, Min Kong, Maowen Ba, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Journal of Alzheimer s Disease